title: MR colonography with fecal tagging: barium vs. barium ferumoxsil.
abstract: OBJECTIVE
  Both magnetic resonance (MR) and computed tomographic (CT) colonography are useful for colon examination. With sensitivities close to those for conventional colonoscopy (CC) for polyps, colonography has been proposed as an alternative to diagnostic CC. MR colonography (MRC) with fecal tagging may be a method of gaining further patient acceptance and widespread use, but the method has to be optimized. The aim of our study was to evaluate the quality of a new contrast agent mixture and to validate a new method for evaluating the tagging efficiency of contrast agents.
  
  
  METHODS
  Twenty patients referred to CC underwent dark lumen MRC prior to the colonoscopy. Two groups of patients received two different oral contrast agents (barium sulfate and barium sulfate/ferumoxsil) as a laxative-free fecal tagging prior to the MRC. After MRC, the contrast agent was rated qualitatively (with the standard method using contrast-to-wall ratio) and subjectively (using a visual analog scale [VAS]) by three different blinded observers.
  
  
  RESULTS
  Evaluated both qualitatively and subjectively, the tagging efficiency of barium sulfate/ferumoxsil was significantly better (P < .05) than barium sulfate alone. The VAS method for evaluating the tagging efficiency of contrast agents showed a high correlation (observer II, r = 0.91) to the standard method using contrast-to-wall ratio and also a high interclass correlation (observer II and III = 0.89/0.85). MRC found 1 of 22 (5%) polyps <6 mm, 2 of 3 (67%) polyps 6-10 mm, and 2 of 2 (100%) polyps >10 mm.
  
  
  CONCLUSIONS
  MRC with fecal tagging using barium sulfate/ferumoxsil as contrast agent will give better overall assessment of the colon wall compared to barium sulfate alone. Furthermore, the VAS method of evaluating fecal tagging efficiency correlated with the standard method of calculating the contrast-to-wall ratio.
authors.affiliation: Department of Radiology, Copenhagen University Hospital, Herlev, Denmark. achiam1@dadlnet.dk
authors.forename: Michael Patrick
authors.initials: MP
authors.lastname: Achiam
authors.forename: Elizaveta
authors.initials: E
authors.lastname: Chabanova
authors.forename: Vibeke Berg
authors.initials: VB
authors.lastname: Løgager
authors.forename: L P H
authors.initials: LP
authors.lastname: Andersen
authors.forename: Henrik Segelcke
authors.initials: HS
authors.lastname: Thomsen
authors.forename: Jacob
authors.initials: J
authors.lastname: Rosenberg
mesh_terms: D001466:Barium Sulfate; D023881:Colonography, Computed Tomographic; D015179:Colorectal Neoplasms / Q000175:diagnosis*; D003287:Contrast Media; D005243:Feces; D005260:Female; D052203:Ferrosoferric Oxide; D019786:Gadolinium DTPA; D006801:Humans; D007501:Iron; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D008297:Male; D010087:Oxides; D012833:Siloxanes
chemical_list: D003287:Contrast Media; D058185:Magnetite Nanoparticles; D010087:Oxides; D012833:Siloxanes; D001466:Barium Sulfate; C088769:ferumoxsil; C064925:gadodiamide; D007501:Iron; D019786:Gadolinium DTPA; D052203:Ferrosoferric Oxide